CVS Health (CVS) Settles FTC Claims, Caps Insulin Costs at $25
Related Stocks: CVS
Read the full articleYou might also wanna read
STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access
The FTC settled a lawsuit against CVS Caremark over allegations that the company artificially inflated the price of insulin and impeded acce
CVS Caremark reaches settlement with FTC over insulin suit
Terms of the deal announced Tuesday are very similar to those the FTC reached with Express Scripts earlier this year, including requiring th
CVS settles with FTC, agrees to count TrumpRx drug purchases towards insurance
By Amina Niasse and Jody Godoy NEW YORK, July 14 (Reuters) - CVS Health's Caremark has finalized a settlement with the U.S. Federal Trade Co
Minnesota wins $850K in settlement with CVS over false Medicaid claims for insulin pens
CVS Pharmacy agreed to pay $36.5 million total to settle a multi-state lawsuit.
CVS settles for $36.5M over false Medicaid insulin claims, Minnesota recovers $400K
Minnesota Attorney General Keith Ellison announced a settlement with CVS, holding the pharmacy chain accountable for years of alleged over b
FTC settles lawsuit with Optum Rx, ending its campaign against the ‘big three’ PBMs
The agency had been suing the three largest pharmacy benefit managers over their alleged control of insulin prices. It reached agreements wi
Comments
Sign in to join the conversation.
No comments yet. Be the first.